Michal Cibulka

4PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - inorganic elements and compoundsNeurology and neuromuscular diseasesAboriginal and Torres Strait Islander sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 26, 2025
Lymphocyte Inhibition Mechanisms and Immune Checkpoints in COVID-19: Insights into Prognostic Markers and Disease Severity.

Martina Schniederova, Anna Bobcakova, Marian Grendar

|Jan 08, 2025
IL-6 Does Not Influence the Expression of SLC41A1 and Other Mg-Homeostatic Factors.

Maria Brodnanova, Michal Cibulka, Marian Grendar

|Aug 10, 2024
The Role of Magnesium in Parkinson's Disease: Status Quo and Implications for Future Research.

Michal Cibulka, Maria Brodnanova, Erika Halasova

|Sep 25, 2019
SNPs rs11240569, rs708727, and rs823156 in SLC41A1 Do Not Discriminate Between Slovak Patients with Idiopathic Parkinson's Disease and Healthy Controls: Statistics and Machine-Learning Evidence.

Michal Cibulka, Maria Brodnanova, Marian Grendar

Pageof 1

Frequent Collaborators

1 joint publications

Milan Grofik

1 joint publications

Maria Brodnanova

1 joint publications

Milos Jesenak